BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23975584)

  • 1. The current spectrum of infection in cancer patients with chemotherapy related neutropenia.
    Nesher L; Rolston KV
    Infection; 2014 Feb; 42(1):5-13. PubMed ID: 23975584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Febrile neutropenia in the tropics: a description of clinical and microbiological findings and their impact on inappropriate therapy currently used at an oncological reference center in Colombia.
    Cortés JA; Cuervo S; Gómez CA; Bermúdez D; Martínez T; Arroyo P
    Biomedica; 2013; 33(1):70-7. PubMed ID: 23715309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia.
    Nakamura A; Sugimoto Y; Ohishi K; Sugawara Y; Fujieda A; Monma F; Suzuki K; Masuya M; Nakase K; Matsushima Y; Wada H; Katayama N; Nobori T
    J Clin Microbiol; 2010 Jun; 48(6):2030-6. PubMed ID: 20392911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy-induced febrile neutropenia: About 186 episodes. Clinical, microbiological and therapeutic characteristics].
    Masmoudi S; Khanfir A; Maalej-Mezghan S; Hammami A; Frikha M
    Tunis Med; 2015 Apr; 93(4):217-22. PubMed ID: 26375737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment.
    Vento S; Cainelli F
    Lancet Oncol; 2003 Oct; 4(10):595-604. PubMed ID: 14554236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the febrile neutropenic patient with cancer.
    Gucalp R
    Oncology (Williston Park); 1991 Jul; 5(7):137-44, 147; discussion 148. PubMed ID: 1837473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia.
    von Lilienfeld-Toal M; Lehmann LE; Raadts AD; Hahn-Ast C; Orlopp KS; Marklein G; Purr I; Cook G; Hoeft A; Glasmacher A; Stüber F
    J Clin Microbiol; 2009 Aug; 47(8):2405-10. PubMed ID: 19571034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the epidemiology of infections in patients with febrile neutropenia].
    Karthaus M; Carratala J
    Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causative Pathogens of Febrile Neutropaenia in Children Treated for Acute Lymphoblastic Leukaemia.
    Lam JC; Chai JY; Wong YL; Tan NW; Ha CT; Chan MY; Tan AM
    Ann Acad Med Singap; 2015 Nov; 44(11):530-4. PubMed ID: 27089960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New pathogens in neutropenic patients with cancer: an update for the new millennium.
    Zinner SH
    Int J Antimicrob Agents; 2000 Oct; 16(2):97-101. PubMed ID: 11053787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.
    Whittle SB; Williamson KC; Russell HV
    Pediatr Hematol Oncol; 2017 Aug; 34(5):331-342. PubMed ID: 29200325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of fever in neutropenic patients.
    Bodey GP; Rolston KV
    J Infect Chemother; 2001 Mar; 7(1):1-9. PubMed ID: 11406750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.
    de Lalla F
    Drugs; 1997 May; 53(5):789-804. PubMed ID: 9129866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial and fungal infections in patients with the acquired immunodeficiency syndrome.
    Rolston KV; Radentz S; Rodriguez S
    Cancer Detect Prev; 1990; 14(3):377-81. PubMed ID: 2386975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia.
    Lamoth F; Jaton K; Prod'hom G; Senn L; Bille J; Calandra T; Marchetti O
    J Clin Microbiol; 2010 Oct; 48(10):3510-6. PubMed ID: 20720024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection among adult small bowel and multivisceral transplant recipients in the 30-day postoperative period.
    Primeggia J; Matsumoto CS; Fishbein TM; Karacki PS; Fredette TM; Timpone JG
    Transpl Infect Dis; 2013 Oct; 15(5):441-8. PubMed ID: 23809406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
    van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006247. PubMed ID: 27107610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.